Ozempic and Wegovy are both brand names for medications used to treat type 2 diabetes and obesity. The drugs mimic the action of a gut hormone that kicks in after people eat, boosting insulin release, blocking sugar production, and suppressing appetite.
- Ozempic (semaglutide) is a type of medication called a GLP-1 receptor agonist. It works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels by stimulating insulin secretion and reducing glucose production in the liver. Ozempic is administered as a once-weekly injection and has been shown to be effective in lowering blood sugar levels and reducing the risk of cardiovascular events in people with type 2 diabetes.
- Wegovy (semaglutide) is a higher-dose version of Ozempic that was recently approved by the FDA as a treatment for obesity. It works in a similar way to Ozempic, but at a higher dose and with a focus on weight loss. Wegovy is also administered as a once-weekly injection and has been shown to be effective in helping people with obesity lose weight and improve metabolic health.
